Osteoporosis Risk Factors and Treatment Strategies
Conduct an analysis of the elements of the research article you identified. Be sure to include the following:
- Your topic of interest.
- A correctly formatted APA citation of the article you selected, along with link or search details.
- Identify a professional practice use of the theories/concepts presented in the article.
- Analysis of the article using the “Research Analysis Matrix” section of the template
- Write a 1-paragraph justification stating whether you would recommend this article to inform professional practice.
- Write a 2- to 3-paragraph summary that you will add to your Academic Success and Professional Development Plan that includes the following:
- Describe your approach to identifying and analyzing peer-reviewed research.
- Identify at least two strategies that you would use that you found to be effective in finding peer-reviewed research.
- Identify at least one resource you intend to use in the future to find peer-reviewed research
Answer the following items using your own words. Be objective and concise while being professional.
1. During a case presentation at your clinic you review four women with predisposing factors for osteoporosis. ,Which patient is least likely to be at risk for osteoporosis?
A. Nehineza, an overweight African American female with a family history of uterine cancer
B. Cristina, a Hispanic woman living a sedentary life
C. Park-Gim-Ka, an underweight Asian woman with a history of tobacco use
D. Skylar, a Caucasian woman experiencing early onset of menopause.
3. After prompt analysis of your patient, you decide to institute treatment for osteoporosis. Which class of medication is considered the first-line treatment? Are there any considerations to be made prior to starting therapy? Which recommendations would you provide to the patient regarding this treatment?
2 PAGES
NO PLAGIARISM MORE THAN 10% PLEASE WILL BE SUBMITTED BY TURNIN IN
3 SCHOLARLY RESOURCES NO OLDER THAN 5 YEARS WITH IN TEXT CITATIONS
APA 7TH EDITION FORMAT
DUE DARTE MARCH 31, 2025